Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

Biomarkers can be defined  as “a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers play an integral part in conducting clinical trials and treating patients. In most instances, they help medical practitioners, researchers, and regulatory officials make well-informed, scientifically sound decisions. More efficient discovery and use of biomarkers in the development of antidiabetes drugs will depend on advancing our understanding of the pathogenesis of diabetes and especially its macrovascular complications.  Methodological advances from other fields, especially oncology, are beginning to pave the way toward improved models of diabetes pathogenesis and biomarker discovery.

  • Prognostic biomarkers
  • Diabetic nephropathy biomarkers
  • Diabetes: Clinical trials and new biomarkers under development
  • Pharmacotherapy in treatment of diabetes
  • Inflammatory markers: Type 2 diabetes
  • New drug treatments and devices for diabetes: current research

Related Conference of Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

June 20-21, 2018

27th European Diabetes Congress

| Rome, Italy
July 16-17, 2018 Sydney, Australia

20th Asia Pacific Diabetes Conference

July 23-24, 2018

Global Meeting on Diabetes and Endocrinology

Kuala Lumpur, Malaysia
August 20-21, 2018

28th World Congress on Diabetes, Obesity & Heart

Tokyo, Japan
September 03-04, 2018

2nd International Conference on Thyroid and Pregnancy

Auckland, New Zealand
September 3-4, 2018

11th World Congress on Endocrinology and Metabolic Disorders

Auckland, New Zealand
November 22-23, 2018

14th World Congress on Endocrinology

Paris , France
September 28-29, 2018

2nd International Conference on Diabetes and Diabetic Nursing Care

Montreal, Quebec, Canada
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland
April 26-27, 2019

12th International Conference on Diabetes & Metabolism

Houston | Texas | USA
Dec 14-15, 2019

Euro Diabetes Congress & Expo

| Prague, Czech Republic

Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes Conference Speakers